‘Pruritic nodules’ are small lumps under the skin that cause itching and which, according to some studies, can remain for several years. A study of whooping cough vaccinations in Gothenburg a few years ago showed that almost one per cent of the children developed pruritic nodules in the area of the vaccination. Three out of four of the children who had a reaction with nodules also developed an allergy to aluminium.
“This was completely unexpected. Aluminium has been used as an adjuvant, intensifier, in vaccines for over 70 years with only a small number of reports of pruritic nodules and allergic contact dermatitis”, says Eva Netterlid. Her research has been carried out at the Occupational and Environmental Dermatology Unit in Malmö.
There are a number of possible explanations as to why aluminium allergy has become more common. There is new technology for identifying the allergy, the type of aluminium compounds used in vaccines and other treatments may have changed, and the number of vaccinations has increased with the increase in international travel.
Eva Netterlid only found a very small number of pruritic nodules in a study of diphtheria vaccinations of Swedish 10-year-olds. She then went on to study hyposensitisation, a treatment in which gradually higher doses of an allergenic substance are given to patients who are allergic to pollen, mites, etc. to habituate them to the substance.
This treatment also uses aluminium as an intensifier. The follow-up in this case showed a higher number of reactions. Of 37 children treated, allergic contact dermatitis from aluminium was seen in 8 children and pruritic nodules in 13 children. The 24 children with allergies who were included in the study but who were not given the treatment had neither pruritic nodules nor aluminium allergy.
Another study was of hyposensitisation of children and adults with allergic respiratory diseases. It was found that almost four per cent of the subjects had allergic contact dermatitis from aluminium. There were individuals with aluminium allergy in both the treated and the untreated group, and the allergy could therefore not be conclusively linked to the treatment. However, examination of the patients’ arms before and one year after the treatment showed that the number of people with nodules had increased significantly, and the proportion who had pruritic nodules had also increased.
Eva Netterlid and her colleagues hope to be able to continue with their research in the area. One important issue is whether different aluminium compounds produce different outcomes; another is whether those who have had a positive result in the test for aluminium allergy also have clinical symptoms when exposed to drugs and cosmetics containing aluminium.
Eva Netterlid can be contacted by telephone, +46 46 18 85 35, +46 708 988535, or by email, email@example.com.
Pressofficer Ingela Björck; firstname.lastname@example.org; +46-46 222 7646
Ingela Björck | idw
The balancing act: An enzyme that links endocytosis to membrane recycling
07.12.2016 | National Centre for Biological Sciences
Transforming plant cells from generalists to specialists
07.12.2016 | Duke University
In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.
Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
07.12.2016 | Health and Medicine
07.12.2016 | Life Sciences
07.12.2016 | Health and Medicine